← Back
Data updated: Mar 10, 2026
ZHEJIANG JUTAI PHARM
Neurology
ZHEJIANG JUTAI PHARM is a generic drug manufacturer focused on Neurology.
2019
Since
3
Drugs
-
Trials
146
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
AMANTADINE HYDROCHLORIDE 2025-12-05
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (2)
Company Info
- First Approval
- 2019-09-05
- Latest
- 2025-07-10
- Applications
- 3